Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial

OBJECTIVES: To test whether Bacillus Calmette-Guérin (BCG) vaccination would reduce the incidence of COVID-19 and other respiratory tract infections (RTIs) in older adults with one or more comorbidities. METHODS: Community-dwelling adults aged 60 years or older with one or more underlying comorbidit...

Descripción completa

Detalles Bibliográficos
Autores principales: Koekenbier, Eva L., Fohse, Konstantin, van de Maat, Josephine S., Oosterheert, Jan Jelrik, van Nieuwkoop, Cees, Hoogerwerf, Jacobien J., Grobusch, Martin P., van den Bosch, Maurice A.A.J., van de Wijgert, Janneke H.H., Netea, Mihai G., Rosendaal, Frits R., Bonten, Marc J.M., Werkhoven, C.H. (Henri) van
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892323/
https://www.ncbi.nlm.nih.gov/pubmed/36736662
http://dx.doi.org/10.1016/j.cmi.2023.01.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892323/
https://www.ncbi.nlm.nih.gov/pubmed/36736662
http://dx.doi.org/10.1016/j.cmi.2023.01.019

Ejemplares similares